Regeneron Provides Update on EYLEA HD (aflibercept) Injection 8 mg Supplemental Biologics License Application
TARRYTOWN, N.Y., April 18, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ:…
Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025
April 16, 2025 07:00 ET | Source: Tonix Pharmaceuticals Holding Corp. CHATHAM,…
Norgine strengthens rare disease portfolio with acquisition of Theravia
Acquisition of Theravia from Mérieux Equity Partners represents meaningful step forward in Norgine's…
Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock
April 11, 2025 16:15 ET | Source: Titan Pharmaceuticals, Inc. NEW YORK,…
AI-Driven 360 Patient Process Optimization and Specimen Management Solution with QIAM Integrated with Epic
Revolutionizing Healthcare with Quake Real-Time UHF RFID process optimization solution for Patients,…
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
April 10, 2025 16:05 ET | Source: Avadel Pharmaceuticals plc DUBLIN, April…
Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients withAcquired Hypothalamic Obesity
Company to host conference call on April 7 at 8 a.m. ET…
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
April 04, 2025 16:05 ET | Source: Syndax Pharmaceuticals, Inc. NEW YORK,…
Anne Whitaker Appointed as Non-Executive Director
April 03, 2025 18:13 ET | Source: Telix Pharmaceuticals Limited MELBOURNE, Australia…
Atea Pharmaceuticals Highlights Actions Underway to Enhance Shareholder Value
March 26, 2025 13:58 ET | Source: Atea Pharmaceuticals, Inc. BOSTON, March…